We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+2.16%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+377.38%
AUM
$881M
AUM Growth
-$121M
Cap. Flow
-$139M
Cap. Flow %
-15.77%
Top 10 Hldgs %
39.5%
Holding
4,106
New
974
Increased
850
Reduced
839
Closed
1,374

Sector Composition

Rank Sector Weight
1 Technology 2.15%
2 Energy 2.14%
3 Industrials 2.11%
4 Financials 2.11%
5 Consumer Discretionary 1.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GSK icon
1101
GSK
GSK
$104B
$25K ﹤0.01%
461
-780
-63% -$41.6K
HAFC icon
1102
Hanmi Financial
HAFC
$959M
$25K ﹤0.01%
+890
New +$25.4K
IPAR icon
1103
Interparfums
IPAR
$4.04B
$25K ﹤0.01%
677
-92
-12% -$3.3K
L icon
1104
Loews
L
$23.6B
$25K ﹤0.01%
539
-249
-32% -$11.7K
MAG
1105
DELISTED
MAG Silver
MAG
$25K ﹤0.01%
1,477
-1,327
-47% -$16.5K
MRIN
1106
DELISTED
Marin Software
MRIN
$25K ﹤0.01%
455
+267
+142% +$16.8K
SOHU
1107
Sohu.com
SOHU
$362M
$25K ﹤0.01%
535
-1,264
-70% -$54.1K
TIPT icon
1108
Tiptree Inc
TIPT
$665M
$25K ﹤0.01%
3,509
+3,329
+1,849% +$22.5K
TWO
1109
Two Harbors Investment
TWO
$1.27B
$25K ﹤0.01%
+313
New +$25K
WINA icon
1110
Winmark
WINA
$1.28B
$25K ﹤0.01%
+190
New +$24K
WM icon
1111
Waste Management
WM
$89.9B
$25K ﹤0.01%
343
-62
-15% -$4.51K
AE
1112
DELISTED
Adams Resources & Energy Inc
AE
$25K ﹤0.01%
+603
New +$24.2K
LUMO
1113
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
$25K ﹤0.01%
372
+307
+472% +$38K
MN
1114
DELISTED
MANNING & NAPIER, INC.
MN
$25K ﹤0.01%
5,918
+5,515
+1,368% +$27.4K
CALA
1115
DELISTED
Calithera Biosciences, Inc
CALA
$25K ﹤0.01%
85
-209
-71% -$55.9K
LEAF
1116
DELISTED
Leaf Group Ltd.
LEAF
$25K ﹤0.01%
3,247
-1,507
-32% -$12.2K
NAVB
1117
DELISTED
Navidea Biopharmaceuticals Inc.
NAVB
$25K ﹤0.01%
+2,454
New +$24.3K
NFX
1118
DELISTED
Newfield Exploration
NFX
$25K ﹤0.01%
881
-3,488
-80% -$115K
COL
1119
DELISTED
Rockwell Collins
COL
$25K ﹤0.01%
236
-886
-79% -$91.8K
ALLE icon
1120
Allegion
ALLE
$14.1B
$24K ﹤0.01%
300
-1,114
-79% -$87.2K
CYBR
1121
DELISTED
CyberArk
CYBR
$24K ﹤0.01%
+479
New +$24.2K
DBVT
1122
DBV Technologies
DBVT
$839M
$24K ﹤0.01%
69
+52
+306% +$17.8K
HLF icon
1123
Herbalife
HLF
$1.33B
$24K ﹤0.01%
670
-270
-29% -$9.1K
IRIX icon
1124
IRIDEX
IRIX
$14.6M
$24K ﹤0.01%
2,433
+854
+54% +$8.41K
KINS icon
1125
Kingstone Companies
KINS
$297M
$24K ﹤0.01%
+1,591
New +$24.1K

Similar funds

Tower Research Capital (TRC)'s Q2 2017 Portfolio in Review

As of Q2 2017, Tower Research Capital (TRC) held 4,106 positions worth $881M, down 12% from $1B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Tower Research Capital (TRC) withdrew a net $139M in Q2 2017, closing 1,374 positions and reducing 839 holdings. Its most notable exit was State Street SPDR S&P Retail ETF, an estimated $5.29M position sold in full.

By sector, the portfolio is most concentrated in Technology at 2.1% of assets, up from 1.5% a quarter earlier, followed by Energy and Industrials.

Against the trend, Tower Research Capital (TRC) opened a new position in State Street Consumer Discretionary Select Sector SPDR ETF worth $17.2M.

  • Tower Research Capital (TRC)'s largest Q2 2017 buy was State Street Consumer Discretionary Select Sector SPDR ETF: 382,942 shares worth $17.2M.
  • Tower Research Capital (TRC) added most to iShares MSCI Emerging Markets ETF in Q2 2017, an estimated $60M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $152M.
  • Tower Research Capital (TRC) fully exited State Street SPDR S&P Retail ETF in Q2 2017, selling an estimated $5.29M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 40% of its $881M portfolio in Q2 2017.
  • Tower Research Capital (TRC) opened 974 new positions and closed 1,374 in Q2 2017.
  • Tower Research Capital (TRC)'s portfolio value fell 12% quarter-over-quarter to $881M.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2017, filed 15 Aug 2017.